Search Within

Raajit Kumar Rampal

  1. "Biostatistics Service"
Formats
  1. Meeting Abstract (20)
  2. Journal Article (17)
  3. Research Letter (2)
Groups
  1. Adult Leukemia (39)
  2. Biostatistics Service (39)
  3. Center for Hematologic Malignancies (39)
  4. Department of Medicine (39)
  5. Epidemiology and Biostatistics (39)
  6. Hematologic Malignancies, Division of (39)

More Groups

People
  1. Sean Devlin (17)
  2. Ross Levine (16)
  3. Andriy Derkach (15)
  4. Eytan Stein (13)
  5. Martin Tallman (13)
  6. Omar Abdel-Wahab (9)

More People

Years
  1. 2025 (1)
  2. 2024 (1)
  3. 2023 (11)
  4. 2022 (4)
  5. 2021 (3)
  6. 2020 (2)

More Years

Publications
  1. Blood (19)
  2. Blood Advances (3)
  3. American Journal of Hematology (2)
  4. British Journal of Haematology (2)
  5. Haematologica (2)
  6. Journal of Clinical Oncology (2)

More Publications

Publishers
  1. American Society of Hematology (22)
  2. John Wiley & Sons (3)
  3. Nature Publishing Group (3)
  4. American Society of Clinical Oncology (2)
  5. Ferrata Storti Foundation (2)
  6. John Wiley & Sons, Inc. (2)

More Publishers

Results (39)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Targeted sequencing reveals a relationship between mutational burden and clinical phenotype in MPNs
    Meeting Abstract

    Getta, B.; Rapaport, F.; Devlin, S.; Zhao, C.; Knapp, K. M.; Patel, M.; Mohanty, A.; Van den Brink, M.; Levine, R. L.; Arcila, M.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Response to hypomethylating agent therapy in acute myeloid leukemia based upon mutations in the DNA methylation pathway
    Meeting Abstract

    Coombs, C. C.; Devlin, S.; Dixit, S.; Mohanty, A.; Knapp, K. M.; Arcila, M.; Klimek, V. M.; Tallman, M. S.; Levine, R. L.; Rampal, R. K.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Telomere length is associated with specific mutations and mutation classes in patients with acute myeloid leukemia
    Meeting Abstract

    Watts, J. M.; Dumitriu, B.; Hilden, P.; Chen, C.; Rapaport, F.; Kishtagari, A.; Ahn, J.; Devlin, S. M.; Rampal, R. K.; Levine, R. L.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • The addition of radiation therapy to initial treatment for extramedullary acute myeloid leukemia does not offer a survival benefit when added to chemotherapy
    Meeting Abstract

    Feller, F. M.; Patel, M.; Devlin, S. M.; Maloy, M.; Tallman, M. S.; Perales, M. A.; Rampal, R. K.
    Blood (2014)

    Fulltext@MSK | Save
  • Treatment with radiation, chemotherapy, or both demonstrates similar outcomes in patients with isolated myeloid sarcoma that may not be different than de novo acute myeloid leukemia
    Meeting Abstract

    Feller, F. M.; Devlin, S. M.; Stein, E. M.; Tallman, M. S.; Rampal, R. K.
    Haematologica (2014)

    Fulltext@MSK | Save
  • High-throughput mutational profiling of post-myeloproliferative neoplasm acute myeloid leukemia reveals frequent mutations in NRAS in JAK2V617F-negative post-MPN AML
    Meeting Abstract

    Rampal, R. K.; Devlin, S. M.; McKenney, A. S.; Knapp, K. M.; Patel, M.; Wang, K.; Nahas, M. K.; Yelensky, R.; Otto, G. A.; Lipson, D.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Integrated genetic profiling of JAK2 wildtype chronic-phase myeloproliferative neoplasms
    Meeting Abstract

    Rampal, R. K.; Devlin, S. M.; Patel, J. P.; Knapp, K. M.; Patel, M.; Greenbowe, J. R.; Young, L. E.; He, J.; Wang, K.; Nahas, M. K.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • High-dose cytarabine monotherapy versus intermediate or high-dose cytarabine in combination with other agents as second-line salvage therapy In patients with acute myeloid leukemia who did not respond to initial induction therapy
    Meeting Abstract

    Dang, T. O. T.; Hilden, P.; Devlin, S. M.; Rampal, R. K.; Levine, R. L.; Berman, E.; Klimek, V. M.; Adel, N. G.; Tallman, M. S.
    Blood (2013)

    Fulltext@MSK | Save
  • Genetic analysis of patients with leukemic transformation of myeloproliferative neoplasms shows recurrent SRSF2 mutations that are associated with adverse outcome
    Journal Article

    Zhang, S. J.; Rampal, R.; Manshouri, T.; Patel, J.; Mensah, N.; Kayserian, A.; Hricik, T.; Heguy, A.; Hedvat, C.; Gonen, M.; more...
    Blood (2012)

    Fulltext@MSK | Save